HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A longitudinal study of porcine serological responses to experimental infections with T-1 and T-3 Spanish Trichinella isolates.

Abstract
Comparison of antibody response and antigen recognition was made by ELISA and western-blot analysis in pig experimental infections by T-1 and T-3 Spanish Trichinella isolates. Two groups of Iberian pigs were experimentally infected with 150 larvae/kg body weight of GM-1 and C-76 Spanish Trichinella isolates as representatives of T-1 and T-3 gene pools respectively. Antibody levels and antigen recognition were measured on days -14, 0, 6, 16, 20, 27, 34, 49, 63 and 82 after infection by ELISA and western-blotting assays. Antibody response against C-76 infection was significantly delayed and lower than against GM-1. The two Trichinella isolates were indistinguishable, however, by western blotting analysis, although recognition of larval antigens was quantitatively higher than adult ones. Interestingly, the principle larval antigenic components recognized by pigs were those recognized by the monoclonal anti-sera NIM-M1. Finally, there were no serological patterns indicative of the stage of infection ("antibody windows") discriminating, for example between early versus late infections.
AuthorsF Bolas, E Albarran, T Garate, R M Parkhouse, A R Martinez
JournalJournal of helminthology (J Helminthol) Vol. 66 Issue 3 Pg. 231-7 (Sep 1992) ISSN: 0022-149X [Print] England
PMID1452998 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Helminth
  • Antigens, Helminth
Topics
  • Animals
  • Antibodies, Helminth (biosynthesis)
  • Antigens, Helminth (immunology)
  • Blotting, Western
  • Enzyme-Linked Immunosorbent Assay
  • Longitudinal Studies
  • Spain
  • Swine
  • Swine Diseases (immunology)
  • Trichinella (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: